Can we tame steroid side effects in sarcoidosis? new study tests two tapering plans

NCT ID NCT07498842

Recruiting now Symptom relief Sponsor: Royal Brompton & Harefield NHS Foundation Trust Source: ClinicalTrials.gov ↗

First seen Apr 09, 2026 · Last updated May 23, 2026 · Updated 8 times

Summary

This study looks at the best way to slowly reduce steroid medication in people with stable sarcoidosis, an inflammatory disease. About 100 adults who have been on a low dose of prednisolone for at least 6 months will be randomly assigned to a standard or a faster tapering schedule. The goal is to see which approach helps more patients safely cut their steroid dose by at least half, reducing long-term side effects like diabetes and bone loss.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOIDOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Royal Brompton Hospital
RECRUITING

London, SW36NP, United Kingdom

Contact

Contact

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

SARCOIDOSIS SARCOIDOSIS